Delivery Order SPE2DB22D2007-SPE2DB25FH9MY

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,956.86 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Cream, a specialty pharmaceutical product, with a performance period through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,743.82 firm-fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution 60ML, a prescription medication. The contract has a period of performance ending on September 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,166.76 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% Cream in 60 gram quantities. The delivery order has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA for the provision of...
This federal contract award, with an ID of SPE2DB22D2006|SPE2DB24FV7QB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Calcipotriene 0.005% Cream in 120 gram quantities, with a total ceiling value of $2,756.96 and an ultimate completion date of January 24, 2024. The contract is a Delivery Order type, with a Firm Fixed Price pricing structure. It is not designated as a...
This federal contract award is for the delivery of Calcipotriene 0.005% Ointment 60GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,053.40 and is a firm-fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a 60 gram tube of the topical drug Calcipotriene-Betameth DP Ointment. The $5,107.63 firm fixed-price delivery order was issued on August 10, 2021 with a completion date of August 11, 2021. The contract award did not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 60ml of Calcipotriene 0.005% Solution, a specialty medication. The contract has a firm fixed price of $4,183.67 and a completion date of May 17, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,681.66 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a specialty medication. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, SPE2DB22D3004|SPE2DB25FPQ96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.11 fixed-price delivery order is for the supply of 60ml of Calcipotriene 0.005% Solution, a topical medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,738.26, is for the supply of 60ml bottles of Calcipotriene 0.005% solution, a topical medication used in the treatment of psoriasis. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH9MY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,111.00 firm fixed-price delivery order contract is for the supply of Calcipotriene 0.005% Cream, a dermatological medication, to support military healthcare programs.

The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract does not have a set-aside designation, indicating open competition.

Generated 6/3/25, 9:47 AM